Lazabemide

Lazabemide

SCHEMBL20769840

NCCNC(=O)c1ccc(Cl)cn1.NCCNC(=O)c1ccc(Cl)cn1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 3/20 1.00
▸ CYP1A2 P05177 1/20 0.60
▸ TSHR P16473 1/20 0.60
▸ NFKB1 P19838 1/20 0.60
▸ MEN1 O00255 1/20 0.58
▸ BLM P54132 1/20 0.58
▸ PMP22 Q01453 1/20 0.58
▸ KMT2A Q03164 1/20 0.58
▸ MALT1 Q9UDY8 1/20 0.51
▸ EGLN1 Q9GZT9 1/20 0.50
▸ MAOA P21397 1/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ DGAT1 O75907 1/20 0.46
▸ HIF1A Q16665 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lazabemide SCHEMBL121998 1.00 MAOB (1.00) MAOBCYP1A2TSHRNFKB1MEN1
Lazabemide SCHEMBL29710899 1.00 MAOB (1.00) MAOBCYP1A2TSHRNFKB1MEN1
Lazabemide SCHEMBL29389663 0.98 MAOB (0.97) MAOBCYP1A2TSHRNFKB1MEN1
Lazabemide SCHEMBL1230476 0.98 MAOB (0.97) MAOBCYP1A2TSHRNFKB1MEN1
SCHEMBL8973342 0.90 MAOB (0.81) MAOBMEN1KMT2AEGLN1MAOA
SCHEMBL19835607 0.86 MAOB (0.76) MAOBMALT1EGLN1MAOANPC1
SCHEMBL8396789 0.83 MAOB (0.71) MAOBKMT2AEGLN1MAOANPC1
SCHEMBL29459609 0.83 MAOB (0.71) MAOBEGLN1MAOANPC1RAB9A
SCHEMBL14329887 0.83 MAOB (0.71) MAOBEGLN1MAOANPC1RAB9A
SCHEMBL29262574 0.83 MAOB (0.71) MAOBEGLN1MAOANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3675838-A1 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS Puretecch LYT, Inc. (US) 2020-07-08 — — EP disclosed
WO-2019046491-A1 LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS ARIYA THERAPEUTICS, INC. (US) 2019-03-07 — — WO disclosed
Send feedback